Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
Cancer Res
; 67(11): 5300-7, 2007 Jun 01.
Article
in En
| MEDLINE
| ID: mdl-17545610
Search on Google
Database:
MEDLINE
Main subject:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Fusion Proteins, bcr-abl
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
/
Immunotherapy
Limits:
Humans
Language:
En
Year:
2007
Type:
Article